Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. The firm specializes in coagulation, immunodeficiency, diabetes, peptide hormones, and kidney diseases. Its portfolio consists of NGAL Test, NGAL ELISA kits, MBL ELISA kits, and Antibody Shop. The company was founded on November 22, 1917 and is headquartered in Hellerup, Denmark.